Abstract
Little is known of the ubiquitous inhibitors of hyaluronidase, molecules that may be important for the deposition of hyaluronan. A reverse hyaluronan-substrate gel procedure is described here that detects such inhibitors, even in crude biological extracts, and is independent of the catalytic mechanism of the target enzyme. Following electrophoresis, hyaluronan-containing gels are incubated in a hyaluronidase solution. Alcian blue-staining bands indicate hyaluronan protected from degradation and the location of hyaluronidase inhibitors. Coordinated use of hyaluronan substrate gel and reverse substrate gel procedures provides estimates of the number and relative molecular sizes of both enzymes and their inhibitors.
Similar content being viewed by others
References
Meyer K, In The Enzymes, edited by Boyer P, Vol. 5 (Academic Press, New York, 1971), pp. 307–20.
Kreil G, Protein Science 4, 1666–9 (1995).
Frost GI, Csóka T, Stern R, Trends Glycosci Glycotech 8, 419–34 (1997).
Csóka TB, Frost GI, Stern R, Invasion Metastasis 17, 297–311 (1997).
Duran-Reynals F, J Exp Med 58, 161–81 (1933).
Haas E, J Biol Chem 163, 63–88 (1946).
Dorfman A, Ott ML, Whitney R, J Biol Chem 174, 621–9 (1948).
Toole BP, In Cell Biology of Extracellular Matrix, edited by Hay ED (Plenum Press, New York, 1991), pp. 149–75.
Weigel PH, Fuller GM, LeBoeuf RD, J Theor Biol 119, 219–34 (1986).
Delpech B, Girard N, Bertr P, Courel M-N, Chauzy C, Delpech A, J Int Med 242, 41–8 (1997).
Itano N, Kimata K, J Biol Chem 271, 9875–8 (1996).
Spicer AP, Augustine ML, McDonald JA, J Biol Chem 271, 23400–6 (1996).
Weigel PH, Hascall VC, Tammi M, J Biol Chem 272, 13 997–14 000 (1997).
Duran-Reynals F, Compt Rend Soc Biol 99, 6–7 (1928).
Duran-Reynals F, Suner Pi J, Compt Rend Soc Biol 99, 1908–11 (1929).
Duran-Reynals F, J Exp Med 50, 327–40 (1929).
Duran-Reynals F, Stewart FW, Amer J Canc 15, 2790–7 (1933).
Chain E, Duthie ES, Brit J Exp Path 21, 324–38 (1940).
Hyman JJ, Friedman BA, Freedler SO, Surg Gynecol Obstet 100, 515–20 (1955).
Fiszer-Szafarz B, Proc Soc Exp Biol Med 129, 300–2 (1968).
Kolaova M, Neoplasma 24, 285–90 (1977).
Snively GG, Glick D, J Clin Invest 29, 1087–90 (1950).
Grais ML, Glick D, J Invest Dermatol 11, 259–73 (1948).
Newman JK, Berenson GS, Mathews MB, Goldwasser E, Dorfman A, J Biol Chem 217, 31–41 (1955).
Mathews MB, Moses FE, Hart W, Dorfman A, Arch Biochem Biophys 35, 93–100 (1952).
Pogrel MA, Low MA, Stern R, Int J Oral Biol 24, 75–80 (1999).
Mathews MB, Dorfman A, Physiol Rev 35, 381–402 (1955).
Guntenhoener MW, Pogrel MA, Stern R, Matrix 12, 388–96 (1992).
Frost GI, Csóka TB, Wong T, Stern R, Biochem Biophys Res Commun 236, 10–15 (1997).
Laemmli UK, Nature 227, 680–5 (1970).
Ghiggeri GM, Ciano G, Ginevri F, Mutti A, Bergamaschi E, Alinovi R, Righetti PG, J Chromat 452, 347–57 (1988).
Mio K, Carrette O, Maibach HI, Stern R, J Biol Chem, 275, 32413–21 (2000).
Afify AM, Stern M, Guntenhoener M, Stern R, Arch Biochem Biophys 305, 434–41 (1993).
De Salegui M, Pigman W, Arch Biochem Biophys 120, 60–7 (1967).
Cherr GN, Meyers SA, Yudin AI, VeVoort CA, Myles DG, Primakoff P, Overstreet JW, Develop Biol 175, 142–53 (1996).
Hunnicutt GR, Mahan K, Lathrop WF, Ramarao CS, Myles DG, Primakoff P, Biol Reprod 54, 1343–9 (1996).
Meyer MF, Kreil G, Aschauer H, FEBS Lett 413, 385–8 (1997).
Johnston JP, Biochem J 59, 620–7 (1955).
Davies M, Nichol LW, Ogston AG, Biochim Biophys Acta 75, 436–8 (1963).
Gramling E, Niedermeier W, Holley HL, Pigman W, Biochim Biophys Acta 69, 552–8 (1963).
Toole BP, Cur Opin Cell Biol 2, 839–44 (1990).
Knudson CB, Knudson W, Faseb J 7, 1233–41 (1993).
Csóka TB, Frost GI, Heng HIHQ, Scherer SW, Mohapatra G, Stern R, Genomics 48, 63–70 (1998).
Kuppusamy UR, Khoo HE, Das NP, Biochem Pharmacol 40, 397–401 (1990).
Kakegawa H, Matsumoto H, Endo K, Satoh T, Nonaka G-I, Nishioka I, Chem Pharm Bull (Tokyo) 11, 5079–82 (1985).
Kakegawa H, Matsumoto H, Satoh T, Planta Med 27, 385–9 (1988).
Toennesen HH, Int J Pharm 50, 91–5 (1989).
Furuya T, Yamagata S, Shimoyama Y, Fujihara M, Morishima N, Ohtsuki K, Biol Pharm Bull 20, 973–7 (1997).
Kakegawa H, Mitsuo N, Matsumoto H, Satoh T, Akagi M, Tasaka K, Chem Phar Bull (Tokyo) 33, 3738–44 (1985).
Kuppusamy UR, Das NP, Experientia 47, 1196–2000 (1991).
Li M-W, Yudin AI, Ve Voort CA, Sabeur K, Primakoff P, Overstreet JW, Biol Reprod 56, 1383–9 (1997).
Stern M, Stern R, Matrix 12, 397–403 (1992).
Frost GI, Stern R, Anal Biochem 251, 263–9 (1997).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mio, K., Stern, R. Reverse hyaluronan substrate gel zymography procedure for the detection of hyaluronidase inhibitors. Glycoconj J 17, 761–766 (2000). https://doi.org/10.1023/A:1010928523877
Issue Date:
DOI: https://doi.org/10.1023/A:1010928523877